Clinical Trial Update: IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of IPI-549 in locally advanced HPV+ and HPV- head and neck squamous cell carcinoma has completed enrollment with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• IPI-549

Snippet

Sponsor: Assuntina G. Sacco, MD | Conditions: Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-07-25